Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

NCT00000478 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-03-25

No results posted yet for this study

Summary

To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.

Conditions

Interventions

DRUG

atenolol

DRUG

nifedipine

DRUG

diltiazem

DRUG

isosorbide dinitrate

PROCEDURE

coronary artery bypass coronary artery bypass

PROCEDURE

angioplasty, transluminal, percutaneous coronary

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Jerome Cohen · St. Louis University

  • Richard Davies · University of Ottawa

  • John Deanfield · St. Bartholomew's Hospital, University of London

  • Mark Ketterer · Henry Ford Hospital

  • Genell Knatterud

  • Hiltrud Mueller · Montefiore Medical Center

  • Pamela Ouyang · Johns Hopkins University

  • Carl Pepine · University of Florida

  • Craig Pratt · Baylor College of Medicine

  • William Rogers · University of Alabama at Birmingham

  • Andrew Selwyn · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-11-30
Completion
1997-06-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000478 on ClinicalTrials.gov